Posted by Michael Wonder on 11 Nov 2022
Cannabidiol for the treatment of patients with seizures caused by tuberous sclerosis complex
8 November 2022 - The Department of Health and Social Care has asked NICE to produce guidance on the use of cannabidiol in the NHS in England.
Cannabidiol is not recommended as an add-on treatment option for seizures caused by tuberous sclerosis complex in people 2 years and over.
